- $67.87bn
- $66.23bn
- $24.09bn
- 85
- 72
- 66
- 88
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 17,256 | 11,079 | 18,625 | 25,628 | 24,091 |
Cost of Revenue | |||||
Gross Profit | 9,274 | 6,103 | 11,875 | 16,160 | 15,284 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 13,557 | 11,623 | 12,523 | 15,662 | 14,488 |
Operating Profit | 3,699 | -544 | 6,102 | 9,966 | 9,603 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 3,545 | -739 | 5,933 | 9,901 | 9,689 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,735 | -605 | 4,664 | 7,759 | 7,594 |
Net Income Before Extraordinary Items | |||||
Net Income | 2,735 | -605 | 4,664 | 7,759 | 7,594 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2,735 | -605 | 4,664 | 7,759 | 7,594 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6.1 | 1.81 | 8.47 | 13.6 | 13.1 |
Dividends per Share | |||||
Special Dividends per Share |